Nanoparticle approaches to combating drug resistance

Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer

(2013) Fan Bai et al.   BIOMATERIALS

The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer

(2013) Jia Zhou et al.   BIOMATERIALS

Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent

(2013) Simon P. Wisnovsky et al.   CHEMISTRY & BIOLOGY

Reversal of Multidrug Resistance by Mitochondrial Targeted Self-Assembled Nanocarrier Based on Stearylamine

(2013) Zhiwen Zhang et al.   MOLECULAR PHARMACEUTICS

Anti-P-glycoprotein conjugated nanoparticles for targeting drug delivery in cancer treatment

(2011) Pantiwa Iangcharoen et al.   ARCHIVES OF PHARMACAL RESEARCH

Redox-Responsive Nanoparticles from the Single Disulfide Bond-Bridged Block Copolymer as Drug Carriers for Overcoming Multidrug Resistance in Cancer Cells

(2011) Yu-Cai Wang et al.   BIOCONJUGATE CHEMISTRY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance

(2011) Alina Shapira et al.   DRUG RESISTANCE UPDATES

Enhanced Chemotherapy of Cancer Using pH-Sensitive Mesoporous Silica Nanoparticles to Antagonize P-Glycoprotein-Mediated Drug Resistance

(2011) I.-P. Huang et al.   MOLECULAR CANCER THERAPEUTICS

Liposome-Encapsulated Doxorubicin Reverses Drug Resistance by Inhibiting P-Glycoprotein in Human Cancer Cells

(2011) Chiara Riganti et al.   MOLECULAR PHARMACEUTICS

Poly(l-lactide)-Vitamin E TPGS Nanoparticles Enhanced the Cytotoxicity of Doxorubicin in Drug-Resistant MCF-7 Breast Cancer Cells

(2010) Po-Yu Li et al.   BIOMACROMOLECULES

F3-Targeted Cisplatin-Hydrogel Nanoparticles as an Effective Therapeutic That Targets Both Murine and Human Ovarian Tumor Endothelial Cells In vivo

(2010) I. Winer et al.   CANCER RESEARCH

Nanomedicinal strategies to treat multidrug-resistant tumors: current progress

(2010) Xiaowei Dong et al.   Nanomedicine

The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin

(2009) Xiao-Bing Xiong et al.   BIOMATERIALS

Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP

(2009) X. Dong et al.   CANCER RESEARCH

Active targeting schemes for nanoparticle systems in cancer therapeutics

(2008) James D. Byrne et al.   ADVANCED DRUG DELIVERY REVIEWS

Therapeutic Nanoparticles for Drug Delivery in Cancer

(2008) K. Cho et al.   CLINICAL CANCER RESEARCH

In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells

(2008) Ken-ichi Ogawara et al.   JOURNAL OF CONTROLLED RELEASE